Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trials in women.

D Battino1

  • 1The Carlo Besta Neurological Institute, Via Celoria 11, 1-20133, Milan, Italy. dbattino@istituto-besta.it

Epilepsy Research
|July 20, 2001
PubMed
Summary
This summary is machine-generated.

Women are increasingly included in clinical trials, ensuring new drugs benefit everyone. Research must now focus on sex-specific effects of antiepileptic drugs (AEDs) for women of all reproductive stages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epilepsy and pregnancy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2003
Same author

[Malformations in the offspring of pregnant women with epilepsy. Presentation of an international registry of antiepileptic drugs and pregnancy (EURAP)].

Revista de neurologia·2002
Same author

Assessment of teratogenic risk.

Epilepsy research·2001
Same author

Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication.

Therapeutic drug monitoring·2001
Same author

Malformations in offspring of women with epilepsy: a prospective study.

Epilepsia·1999
Same author

Intrauterine growth in the offspring of epileptic women: a prospective multicenter study.

Epilepsy research·1999
Same journal

Comment on "Predictors of surgical outcome in frontal lobe epilepsy: Experience from a single-center cohort in Latin America".

Epilepsy research·2026
Same journal

Response to: "A critical appraisal of principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam".

Epilepsy research·2026
Same journal

Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

Epilepsy research·2026
Same journal

Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

Epilepsy research·2026
Same journal

Diagnostic accuracy of artificial intelligence models for seizure outcome prediction after epilepsy surgery: A systematic review and meta-analysis.

Epilepsy research·2026
Same journal

Quality assessment of persian epilepsy mobile applications: A systematic review using uMARS and DISCERN.

Epilepsy research·2026
See all related articles

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Women's Health

Background:

  • Historically, women of childbearing age were excluded from clinical trials, often deemed a 'vulnerable population'.
  • Recent policy shifts have led to increased female participation in clinical trials.
  • This change promotes respect for women's autonomy in healthcare decisions and ensures equitable access to new medications.

Purpose of the Study:

  • To advocate for the inclusion of women in clinical trials.
  • To emphasize the need for gender-specific analysis of drug efficacy and tolerability, particularly for antiepileptic drugs (AEDs).
  • To highlight critical considerations for women across reproductive stages, including pregnant and lactating individuals.

Main Methods:

  • Review of historical exclusion and recent policy changes regarding women in clinical trials.

Related Experiment Videos

  • Discussion of the implications of increased female participation.
  • Identification of key areas for future research in sex-specific drug evaluation.

    • Main Results:

    • Increased participation of women in clinical trials respects their decision-making capacity.
    • Early evaluation of drugs in the ultimate user population (women) is now possible.
    • Equal opportunities for women to benefit from therapeutic advancements are being established.

    Conclusions:

    • Clinical trials must be designed to identify sex-related effects of drugs, especially antiepileptic drugs (AEDs).
    • Research should address menstrual cycle, reproductive stages, hormonal therapy interactions, reproductive function, and prenatal exposure effects.
    • Special attention is crucial for pregnant and lactating women, prioritizing offspring safety unless maternal benefits are substantial.